Hidradenitis Suppurativa Remission and Progression in a Community Setting
This cohort study found that estimates from hospital-based cohorts likely overstate HS disease progression and underestimate its remission. In this community-based cohort, HS progression to severe disease was 10.4 times lower and rates of HS remission were 3.8 times higher than reported within hospitals, suggesting a more favorable disease course than previously reported.
Authors
- Liv Eidsmo (ORCID: https://orcid.org/0000-0001-9237-8374)
- Christina Ellervik (ORCID: https://orcid.org/0000-0002-3088-4375)
- Rune Kjærsgaard Andersen (ORCID: https://orcid.org/0000-0003-0159-670X)
- Morten Kranker Larsen (ORCID: https://orcid.org/0000-0002-2873-5928)
- Ditte Marie Lindhardt Saunte (ORCID: https://orcid.org/0000-0001-7953-1047)
- Gregor B. E. Jemec (ORCID: https://orcid.org/0000-0002-0712-2540)
- Ole Lederballe Pedersen
Institutions
- University of Copenhagen (DK)
- Boston Children's Hospital (US)
- Karolinska University Hospital (SE)
- Harvard University (US)
- Gentofte Hospital (DK)
- Karolinska Institutet (SE)
- Zealand University Hospital (DK)
- Zealand University Hospital Køge (DK)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1001/jamadermatol.2025.4700
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00